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Abstract  Congenital  ﬁber-type  disproportion  myopathy  causes  impaired  muscle  maturation
or development.  It  is  characterized  by  moderate  to  severe  hypotonia  and  generalized  muscle
weakness  at  birth  or  during  the  ﬁrst  year  of  life,  especially  in  the  lower  extremities.  It  is
inherited  as  an  autosomal  recessive,  dominant  and  X-linked.  It  is  diagnosed  by  clinical  data
conﬁrmation,  generalized  hypotonia  and  a  muscle  biopsy  in  which  muscle  ﬁbers  type  I are
smaller in  caliber,  12%  smaller  than  those  of  type  II  and  type  I  ﬁbers  are  more  common  than
type II.  Treatment  is  multidisciplinary.
The  following  describes  the  case  of  a  patient  who  was  born  in  the  ‘‘Dr.  José  Eleuterio
González’’  University  Hospital  in  Monterrey,  N.L,  who  presented  clinical  and  muscle  biopsy
compatible  with  this  myopathy.
© 2014  Universidad  Autónoma  de  Nuevo  León.  Published  by  Masson  Doyma  México  S.A.  All  rights
reserved.
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ithin  congenital  myopathies  classiﬁcations,  there  are
yopathies  with  alterations  in  muscle  maturation  and/or
evelopment.  One  of  these  myopathies  is  congenital  ﬁber-
ype  disproportion,  which  is  characterized  by  generalized
uscle  weakness  at  birth  or  during  the  baby’s  ﬁrst  year,
ainly  in  the  extremities.1,2
It  was  ﬁrst  described  by  Brooke  and  Engel1,3 in  a  study
f  the  morphology  of  children’s  biopsies.  It  is  a  rare
asson Doyma México S.A. All rights reserved.
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ceps  were  performed,  conﬁrming  the  congenital  ﬁber-type
disproportion  diagnosis.
The  sample  was  divided  into  two  parts;  the  ﬁrst  part
was  cut  by  freezing  it  and  processed  following  standardCongenital  ﬁber-type  disproportion  myopathy  
entity,  which  occurs  in  1  in  every  50,000  live  births.4 All
body  musculature  is  affected.  However,  the  muscles  in
the  lower  extremities  are  usually  more  altered  than  the
upper  extremities;  thus  the  electromyography  reports  a
myopathic  process,  although  in  others  there  is  a  neurogenic
component.11,13 Some  cases  with  a  longer  evolution  time
show  mild  sclerosis5 and  there  have  been  reports  of  impor-
tant  respiratory  alterations,  severe  brain  damage  and  heart
diseases.1,7,8 In  a  few  cases  an  association  of  skeletal  and
articular  alterations  has  been  observed.9,10
Clinical case
The  mother  of  the  baby  boy  was  a  25-year-old  woman,  pre-
viously  healthy,  secondary  school  completed,  without  drug
addictions,  living  together  with  her  partner.  The  father  was
a  30-year-old  man,  healthy,  without  any  relevant  history.
The  newborn  had  two  other  brothers,  a  4-year-old  and  a
7-year-old,  both  healthy.
The  product  of  a  fourth  pregnancy,  the  mother  had  had
two  C-sections  performed  and  suffered  a  miscarriage  when
she  was  9  weeks  pregnant.  She  completed  a  normal  preg-
nancy,  with  folic  acid,  iron  intake,  as  well  as  supplementary
multivitamins  for  the  ﬁrst  month  of  pregnancy,  prenatal
control  with  8  visits  to  the  University  Hospital  without  pre-
senting  abnormalities.
Born  by  elective  C-section  due  to  the  history  of  two  pre-
vious  C-sections  at  38.4  weeks  of  gestation,  with  an  Apgar
score  of  2/6  because  it  was  found  to  be  acrocyanotic,  ﬂac-
cid,  no  respiratory  effort,  and  with  a  heart  rate  of  80  bpm.
He  is  given  2  positive  pressure  ventilation  cycles,  improv-
ing  hear  rate,  but  not  respiratory  effort,  and  was  therefore
intubated  and  left  under  mechanical  ventilation  and  moved
to  the  Neonatal  Intensive  Care  Unit.
During  physical  examination:  Weight:  3070  g,  located  in
the  50th  percentile,  size:  50  cm,  in  the  50th  percentile,
cephalic  perimeter:  (CP)  36  cm,  in  the  50th  percentile,  myo-
pathic  facies  with  an  elongated  face,  symmetrical  eyes  and
a  bilateral  ptosis,  presenting  red  reﬂex,  permeable  nostrils,
proper  ear  implantation,  an  ogival  palate  and  a  tented  upper
lip.  Neck:  retrognathial,  short,  round.  Thorax:  no  respiratory
effort,  without  deformities,  normal  lung  ﬁelds,  holosystolic
murmur  grade  3--4  detected.  The  abdomen  was  soft,  pal-
pable  without  pain,  and  free  of  visceromegaly,  an  umbilical
cord,  2  arteries  and  a  vein.  Male  genitalia:  Tanner  1,  right
cryptorchidie,  with  the  right  testicle  in  the  inguinal  canal
and  the  left  testicle  in  the  scrotal  bag.  The  extremities:  gen-
eralized  hypotonia,  no  response  to  painful  stimulus,  absence
of  muscle  tone,  deep  tendon  reﬂexes  absent,  rigid  right
clubfoot.
Upon  admission,  gasometry  and  asphyctic  proﬁle  on
admission  and  at  24  h  (due  to  perinatal  asphyxia  suspicion)
were  normal  and  a  transfontanellar  ultrasound  (TFUS)  and
brain  MRI  were  performed  and  were  also  normal  (Fig.  1).
No  infection-compatible  alterations  were  found,  as  well  as
the  metabolic  panel  (with  electrolytes)  and  the  metabolic
screening  were  also  normal.  An  electrocardiogram  was  per-
formed  due  to  the  presence  of  ICT  in  0.62  (Fig.  2)  and  due  to
the  holosystolic  murmur  grade  II/VI  detecting  an  interven-
tricular  communication  of  2  mm,  mild  tricuspid  insufﬁciency,Figure  1  Normal  MRI.
 persistence  of  a  patent  ductus  arteriosus  of  1.4  mm  and  an
val  foramen  without  hemodynamic  repercussions.
We  referred  the  patient  to  the  Genetics  Department  who
valuated  the  patient’s  genealogical  tree,  without  ﬁnding
ny  history  of  neuromuscular  diseases  in  any  of  the  ﬁrst-
egree  relatives  or  extended  family,  thus  classifying  this
s  an  isolated  case.  Furthermore,  they  requested  a  genetic
utations  study;  however,  the  family  did  not  have  the  eco-
omic  resources  to  have  it  done.
Due  to  the  newborn’s  hypotonic  diagnosis,  a  muscle
iopsy,  lab  tests  and  normal  imagining  of  the  right  quadri-Figure  2  Cardiothoracic  index  at  0.62.
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Cross-section, NADH-tr
Type I fibers dark and type II clear.
ATPasa, cross-section Ph 9.4
Type I fibers clear and type II dark.
Cross-section, H-E M.O.A.R., Toluidine blue Cross-section, modif. Tric. Gomori
Figure  3  Type  I  ﬁbers  are  dark  and  small  in  all  the  cuts  except  the  ATPasa  cross-section,  where  type  I  ﬁbers  are  small,  but  clear.
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gype I  ﬁbers  are  atrophic.
ype  II  ﬁbers  are  clear  and  hypertrophic,  with  the  exception  of
nd  special  techniques  for  its  morphological,  histochemi-
al  and  enzymatic  analyses,  applying  H&E  stains,  a  modiﬁed
omori  trichrome  and  ATPase  reactions  at  pH  4.3,  4.6
nd  9.4,  Nicotinamide  dinucleotide  and  adenine-tetrazolium
eductase  (NADH-tr).  In  addition,  we  conducted  a  mor-
hological  study  using  light  microscopy  and  high-resolution
ptics  microscopy.  A  morphometric  analysis  was  conducted
n  type-I  and  type-II  ﬁbers.  Findings  showed  the  following:
t  was  determined  that,  regarding  type-I  ﬁbers,  20%  of  them
ere  within  the  normal  interval  (10--15.4  m)  with  an  aver-
ge  of  6.9  m  (normal  of  12.7  m)  and  a  variable  coefﬁcient
f  449  (normal  up  to  250)  due  to  the  80%  of  atrophic  ﬁbers,
ith  a  very  elevated  atrophy  coefﬁcient  of  1,350  (normal  up
o  150).  For  type-II  ﬁbers,  the  average  was  15.4  m  (normal
0.9  m)  with  just  38%  of  ﬁbers  within  the  normal  inter-
al  (7.7--14.1  m),  the  variable  coefﬁcient  does  not  exceed
he  limit  value  {241  (normal  up  to  250)} despite  the  high
ercentage  of  hypertrophic  ﬁbers  (62%)  but  the  hypertro-
hy  coefﬁcient  is  very  elevated  {600  (normal  up  to  400)}
Fig.  3).
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ongenital  ﬁber-type  disproportion  myopathy,  as  displayed
n  our  patient  in  this  case,  is  determined  by  the  uneven-
ess  in  the  size  of  both  types  of  muscle  ﬁbers,  where  type-I
bers  are  much  smaller,  and  type-II  ﬁbers  are  too  large.1,2ccording  to  the  study  by  Brooke  and  Engel  of  the  morphol-
gy  of  biopsies,  the  entity  is  based  histopathologically  in  a
hreshold  of  12%  of  unevenness  in  ﬁber  sizes  to  deﬁne  the
roup.13
w
b
mATPasa  cross-section,  where  they  are  hypertrophic  but  dark.
Our  patient’s  case  is  relevant  because  congenital  ﬁber-
ype  disproportion  myopathy  is  a  rare  entity,  which
ccording  to  medical  literature  occurs  only  in  1:50,000
ive  births.3,13 The  most  common  clinical  manifestations  in
0--75%  of  cases  are  moderate  to  severe  hypotonia  (ﬂoppy
abies),  general  muscle  weakness  at  birth  or  during  the
rst  year,  especially  in  the  lower  extremities,  and  absence
f  deep  tendon  reﬂexes,  which  the  patient  displayed  in
ur  case,  normal  or  slightly  increased  creatine  kinase  (CK),
ormal  intelligence,  as  well  as  normal  electromyography
r  myopathic  pattern.3,6 Common  clinical  manifestations,
hich  are  present  in  10--50%  of  cases  are:  myopathic  facies
ith  an  elongated  face,  an  ogival  palate,  a  tented  upper
ip  and  light  to  severe  respiratory  problems,  all  of  which
ere  found  in  our  patient,  difﬁculty  feeding,  ophthalmo-
legia,  contractures,  scoliosis,  lordosis  and  laxity.11,12 The
ess  frequent  manifestations,  present  in  less  than  10%  of
ases  are:  cardiac  involvement,  cognitive  impairment  and
ryptorchidism,  which  was  present  in  our  clinical  case.3,6
It  is  a genetically  heterogeneous  disease,  which  in
nherited  in  an  autosomal  recessive  manner,  dominant  and
ith  isolated  cases.1,2,9,12 To  date,  mutations  in  six  genes
ave  been  identiﬁed:  ACTA1  (6%),  MYH7  (unknown),  RYR1
10--20%),  SEPN1  (rare),  TPM2  (rare)  and  TPM3  (20--25%).16
During  the  muscular  biopsy,  we  found  type  I  muscular
bers  of  a  smaller  caliber  (12%  smaller)  than  the  type  IIs,
hich  were  found  to  be  hypertrophic.  And  in  the  same  way
e  found  the  type  I  or  atrophic  ﬁbers,  we  also  found  a
reater  number  of  type  II  or  hypertrophic14,15 ﬁbers,  which
ere  found  in  the  immunohistological  report  of  the  muscular
iopsy  performed  in  the  case  of  our  patient.
The  best  threshold  for  the  level  of  disproportion  of
uscle  ﬁbers  necessary  to  make  a  diagnosis  is  still  under
11
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discussion,  but  there  is  a  general  consensus  that  it  should
be  equal  to  or  greater  than  12%.  The  prenatal  diagnosis  is
made  by  analyzing  DNA  extracted  from  fetal  cells  with  a
chorionic  villus  sampling  at  10  or  12  weeks  of  gestation  and
an  amniocentesis  at  15  to  18  weeks  of  gestation,  where  the
mutation  in  some  of  the  3  genes  causing  the  disease  can  be
found.3,13
The  treatment  is  multidisciplinary,  with  physical  rehabil-
itation  and  treatment  of  complications  such  as  respiratory
difﬁculties,  joint  alterations,  weakness  and  swallowing
difﬁculties.3,13
The  prognosis  depends  on  the  degree  of  hypotonia  as
well  as  respiratory  and  cardiac  involvement.  Ophthalmople-
gia,  ptosis,  a  bulbous  or  weak  face,  severe  weakness  in  the
extremities  and  respiratory  weakness  have  been  described
as  factors  for  a  negative  prognosis.3,11,13
The  presentation  of  this  clinical  case  is  important,  as  it
deals  with  an  infrequent  entity,  which  represents  a diag-
nostic  and  therapeutic  challenge  in  our  line  of  work.  It  is
important  to  get  to  know  the  clinical  manifestations,  how
to  arrive  at  a  diagnosis,  and  understand  the  complications
which  may  arise  in  these  patients,  to  provide  adequate
treatment,  prevent  complications,  and  offer  a  better  quality
of  life.  Additionally,  the  presentation  of  this  case  opens  the
doors  to  more  diagnostic  possibilities  which  we  should  look
forward  to  cope  with  a  newborn  with  generalized  hypotonia.
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